The intervertebral disc is believed to be the key pathology behind low back pain (LBP). The pain mechanisms include annular ruptures, fissures in the end plates, neural sensors on the disc surface causing muscle stimulation, 1 in combination with various biochemical reactions, particular involving cytokines. Disc herniations are not dealt with this review.
Intradiscal treatments have been used and tested over the years. The theories behind the first such treatments, chymopapain and intra-discal electro-thermal therapy (IDET), was the mechanical issue that the jelly-like and toxic nuclear material may penetrate through the annular ruptures. Probably, Mother Nature has decided that when annular ruptures become a problem, nucleus should be more fibrotic preventing its penetration. If this fibrosing can be accelerated in an early degenerated phase, part of the problem might be reduced. Later years, injection treatments rather consider the biochemical aspects.
Such treatments will briefly be discussed in the article. For them all, the demonstrated likelihood of later developed degeneration is a potential disadvantage for any intradiscal injection.
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Chymopapain
There is still some evidence for its value in herniated discs although this is less beneficial than surgery. Regarding back pain, studies are not sufficient to conclude its possible relevance.
Intradiscal Electro-Thermal Therapy
The hypothesis is that a fibrosing of the nucleus, or a closening of ruptures at the inner annulus wall, would decrease the likelihood of nucleus' penetration through annular ruptures. As often seen, the first RCT showed a bright effect, but the following three only a small or no effect at all. A meta-analysis and further discussion questions a relevant clinical effect.
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Methylene Blue
In 2010, Peng et al published a remarkable RCT showing a tremendous LBP and Oswestry reduction remaining at 2 years follow-up. Whereas, the controls only dropped slightly.6 The debate has been tremendous, and later small, open series failed to be that positive, one only a short effect, the other no effect. Status is that most centers are waiting for ongoing further studies.
Stem cells
Stem cells are probably a perspective area. However, it may not be beneficial to regenerate nucleus if it is true that it becomes fibrotic to reduce its protrusion through annular ruptures. More logical would it be to regenerate annulus, which seems more difficult. So far, no RCT exists illustrating optional clinical value.
Steroid
The evidence for intradiscal steroid injections in "usual" discogenic back pain is weak.
7 However, in case of MC-1 changes two small moderate-sized studies indicated significant clinical effects.
8 This conclusion has to be verified further, but most remarkably: if the bacteria theory is true, no infectious flare up was observed.
Antitumor Necrosis Factorα
One of two RCTs on discogenic pain without MCs with intradiscally etanercept revealed some positive effect (Sainoh, ISSLS 2013) . Local treatment on the outside of the disc has in a small, randomized study, intending to test leg pain in herniation, also showed reduction in back pain. 
